113 related articles for article (PubMed ID: 10901591)
1. B-lymphocytes in CLL and NHL differ in the mRNA splicing pattern of the CD45 molecule.
Yu Y; Rabinowitz R; Polliack A; Ben-Bassat H; Schlesinger M
Eur J Haematol; 2000 Jun; 64(6):376-84. PubMed ID: 10901591
[TBL] [Abstract][Full Text] [Related]
2. Hyposialated 185 kDa CD45RA+ molecules attain a high concentration in B lymphoma cells and in activated human B cells.
Yu Y; Rabinowitz R; Polliack A; Ben-Bassat H; Schlesinger M
Eur J Haematol; 2002 Jan; 68(1):22-30. PubMed ID: 11952818
[TBL] [Abstract][Full Text] [Related]
3. A point mutation within CD45 exon A is the cause of variant CD45RA splicing in humans.
Zilch CF; Walker AM; Timón M; Goff LK; Wallace DL; Beverley PC
Eur J Immunol; 1998 Jan; 28(1):22-9. PubMed ID: 9485182
[TBL] [Abstract][Full Text] [Related]
4. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
[TBL] [Abstract][Full Text] [Related]
5. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the expression of CD45 isoforms in the Farage human B cell lymphoma line and its 10.6.1 subline.
Rabinowitz R; Yu Y; Belov E; Shubinsky G; Ben-Bassat H; Schlesinger M
Leuk Lymphoma; 2001 May; 41(5-6):643-54. PubMed ID: 11378582
[TBL] [Abstract][Full Text] [Related]
7. Expression of interleukin 10 in B lymphocytes of different origin.
Finke J; Ternes P; Lange W; Mertelsmann R; Dölken G
Leukemia; 1993 Nov; 7(11):1852-7. PubMed ID: 7694007
[TBL] [Abstract][Full Text] [Related]
8. Very low levels of surface CD45 reflect CLL cell fragility, are inversely correlated with trisomy 12 and are associated with increased treatment-free survival.
Rizzo D; Lotay A; Gachard N; Marfak I; Faucher JL; Trimoreau F; Guérin E; Bordessoule D; Jaccard A; Feuillard J
Am J Hematol; 2013 Sep; 88(9):747-53. PubMed ID: 23733486
[TBL] [Abstract][Full Text] [Related]
9. The alternative splicing of the CD45 tyrosine phosphatase is controlled by negative regulatory trans-acting splicing factors.
Rothstein DM; Saito H; Streuli M; Schlossman SF; Morimoto C
J Biol Chem; 1992 Apr; 267(10):7139-47. PubMed ID: 1532394
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD45 isoforms lacking exons 7, 8 and 10.
Virts E; Barritt D; Raschke WC
Mol Immunol; 1998 Feb; 35(3):167-76. PubMed ID: 9694517
[TBL] [Abstract][Full Text] [Related]
11. Expression of the low Mr isoform of CD45 (CD45RO) in B-cell non-Hodgkin's lymphomas.
Caldwell CW; Marty LM; Feldbush TL
Clin Immunol Immunopathol; 1991 Mar; 58(3):377-84. PubMed ID: 1825807
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD45 isoforms by Epstein-Barr virus-transformed human B lymphocytes.
Marty LM; Caldwell CW; Feldbush TL
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):8-15. PubMed ID: 1370260
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of the hPim-2 gene in human chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Cohen AM; Grinblat B; Bessler H; Kristt D; Kremer A; Schwartz A; Halperin M; Shalom S; Merkel D; Don J
Leuk Lymphoma; 2004 May; 45(5):951-5. PubMed ID: 15291354
[TBL] [Abstract][Full Text] [Related]
14. G protein subunit G alpha 16 expression is restricted to progenitor B cells during human B-cell differentiation.
Mapara MY; Bommert K; Bargou RC; Leng C; Beck C; Ludwig WD; Gierschik P; Dörken B
Blood; 1995 Apr; 85(7):1836-42. PubMed ID: 7703490
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL).
Frolova EA; Richards SJ; Jones RA; Rawstron A; Master PS; Teasdale J; Short M; Jack AS; Scott CS
Leuk Lymphoma; 1995 Jan; 16(3-4):307-18. PubMed ID: 7719238
[TBL] [Abstract][Full Text] [Related]
16. Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia.
Marantidou F; Dagklis A; Stalika E; Korkolopoulou P; Saetta A; Anagnostopoulos A; Laoutaris N; Stamatopoulos K; Belessi C; Scouras Z; Patsouris E
Blood Cells Mol Dis; 2010 Apr; 44(4):262-7. PubMed ID: 20117026
[TBL] [Abstract][Full Text] [Related]
17. The role of alternative splicing of the adhesion molecule, CD44, in lymphoid malignancy.
Irving JA; Cain G; Howard M; Angus B; Taylor PR; Cattan AR
J Clin Pathol; 1998 Oct; 51(10):776-80. PubMed ID: 10023342
[TBL] [Abstract][Full Text] [Related]
18. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation.
Lemaire R; Winne A; Sarkissian M; Lafyatis R
Eur J Immunol; 1999 Mar; 29(3):823-37. PubMed ID: 10092085
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin V gene utilization in chronic lymphocytic leukemia and non-Hodgkin's B cell lymphomas.
Kipps TJ
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):293-8. PubMed ID: 3065730
[TBL] [Abstract][Full Text] [Related]
20. Different types of in vivo induced cytolytic T lymphocytes are all LFA-Ihigh and lack CD45 exon 4 (CD45RA) but show distinct CD45RC profiles.
Hansson J; Ericsson PO; Widegren B; Dohlsten M; Sjögren HO; Hedlund G
Int Immunol; 1994 Sep; 6(9):1375-81. PubMed ID: 7819146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
